Medtronic CEO Omar Ishrak: Emerging markets "the most important ones"
Emerging medical device markets will play a huge role in Medtronic's strategy moving forward and the U.S.'s Affordable Care Act won't, according to Medtronic CEO Omar Ishrak.
Although the U.S. and Europe remain important drivers of Medtronic's ongoing success, emerging markets may be the "the most important ones," according to medtech industry monolith Medtronic's CEO Omar Ishrak.
Emerging markets have figured large in Ishrak's vision from the moment he took over as CEO for the medical device giant last year, especially in China, which makes up about 40% of Medtronic's emerging-market sales, he told CNNMoney.
Although Europe, the U.S. and other developed markets will continue to play a large role in advancing clinical knowledge and technology during the next decade, emerging markets will take over as the most important end markets, Ishrak said.